Summary

The global udder health market is projected to reach USD 1.6 billion by 2029 from USD 1.2 billion in 2024 at a CAGR of 5.9%. The competitive landscape includes the analysis of the key growth strategies adopted by major players between January 2020 and May 2024. Players in the global udder health market have employed various strategies to expand their global footprint and increase their market shares such as agreements, divestitures, expansions, and acquisitions.

“The Devices segment accounted the second-largest market share in the udder health market.”
In the udder health market, the Devices segment holds the second-largest share because of the growing use of equipment like teat sprayers, teat dip applicators, milk quality analyzers, and mastitis detectors. These devices play a crucial role in maintaining the health of dairy cow udders by preventing infections and ensuring milk quality. Farmers increasingly adopt these tools to improve dairy production efficiency and animal welfare standards. The rise in demand is fueled by advancements in technology that enhance the accuracy and effectiveness of these devices, making them indispensable in modern dairy farm operations.

“Dairy farms segment of the udder health market is expected to witness the fastest CAGR.”
By veterinary care setting type, the dairy farms segment has witnessed the fastest growth rate in the udder health market. This is largely because small and medium-scale dairy farms are gradually switching from manual milking to mechanized milking systems. This transition helps improve udder health by reducing the risk of infections like mastitis, ensuring more consistent and hygienic milking processes. As a result, these farms are better able to produce high-quality milk, which drives the segment's rapid growth.

“The Dairy cattle segment of the udder health market accounted for the largest market share.”
Based on animal type, the dairy cattle segment accounted for the largest market share in the udder health market because of growing demand for milk and milk products. Dairy cattles are crucial for milk production, making their udder health vital for consistent supply. Farmers focus on keeping their cows healthy to ensure high-quality milk production, which drives the market for udder health products and services. This segment's dominance reflects the industry's emphasis on maintaining cow health to meet the rising global demand for milk and dairy products.

“Clinical mastitis segment of the udder health market is expected to witness the fastest CAGR.”
By disease type, the clinical mastitis has experienced the fastest CAGR, in the udder health market, due to rising cases of mastitis and other related issue. The increasing prevalence of this disease has driven demand for effective treatments and management solutions within the market. As dairy farms strive to maintain herd health and productivity, there's a growing emphasis on products and practices that can prevent and treat mastitis effectively, contributing to the segment's rapid growth in the udder health industry.

“North America to have the second largest market share in the udder health market during the forecast period.”
North America holds the second largest share in the udder health market. This is mainly because farmers in this region have higher incomes, allowing them to invest more in the health and care of their dairy cows. As their earnings grow, they can afford better products and services to maintain the udder health of their livestock. This increase in spending power boosts the market, making North America a significant player in this sector.


A breakdown of the primary participants (supply side) for the udder health market referred to for this report is provided below:
• By Company Type: Tier 1–35%, Tier 2–25%, and Tier 3–40%
• By Designation: C-level–45%, Director Level–25%, and Others–30%
• By Region: North America–36%, Europe–26%, Asia Pacific–21%, Latin America-10%, and Middle East & Africa_ 7%
A breakdown of the primary participants (demand side) for the udder health market refer to for the report is provided below:
• By Veterinary Care Setting Type: Dairy Farms-65%, Veterinary Hospitals and Clinics-35%
• By Designation: Farm Owners-55%, Veterinarians-45%
• By Region: North America–34%, Europe–27%, Asia Pacific–23%, Latin America-9%, and Middle East & Africa-7%


Key Market Players:
The prominent players in the udder health market include Vetoquinol S.A. (France), Zoetis Inc. (US), Merck & Co., Inc. (US), Virbac (France), Ecolab (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), DeLaval (Sweden), Orffa (Netherlands), AHV International (Netherlands), Boumatic LLC (US), GEA Group Aktiengesellschaft (Germany), G Shepherd Animal Health (UK), Ceva Sante Animale (France), Albert Kerbl GmbH (Germany), Ambic Equipment Limited (England), Lely (Netherlands), Zenex Animal Health India Private Limited (India), Draminski S.A. (Poland), Ring Biotechnology Co Ltd. (China), Nicosia Biolabs International Private Limited (India), Blackmango Herb (India), Koru Diagnostics Ltd. (New Zealand), Mastaplex (New Zealand), and AR Brown Co., Ltd. (Japan).

Research Coverage:
The market analysis examines the udder health market in numerous segments. It seeks to estimate the market size and growth potential across many segments, including product, veterinary care setting, animal type, disease type and geography. The study also includes a detailed competitive analysis of the market's top competitors, as well as company profiles, significant insights about their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The study will assist industry leaders/new entrants in this market by providing information on the closest approximations of the udder health market and its segments. This research will assist stakeholders understand the competitive landscape, obtaining insights to better position their firms, and developing appropriate go-to-market strategies. The study will also assist stakeholders in understanding the market pulse and obtaining information on major market drivers, constraints, opportunities, and challenges.


This report provides insights into the following pointers:
 Analysis of key Drivers: Drivers (Increasing Demand of Milk and Dairy Products, Increasing number of veterinary practitioner in developed economies, Increasing Incidence of Mastitis and Other Udder Health Disorders, Technological Advancements in Udder Health Monitoring), Restrains (Lack of Awareness and Education Among Small-Scale Dairy Farmers), Opportunities (Gradual transitions of small and medium-scale dairy farms from manual milking to mechanized milking solutions, Increasing per capita income of farmers in developing countries), Challenges (Regulatory control on livestock industry to reduce outbreak of diseases) influencing the growth of the udder health market.
• Market Penetration: Comprehensive information on the product portfolios of the leading companies in the udder health market. The report breaks down the market by product type, veterinary care setting types, animal types, disease types and region.
• Product Enhancement/Innovation: Detailed information about forthcoming trends and product launches in the udder health market.
• Market Development: Comprehensive data on attractive rising markets broken down by product category, veterinary care setting types, animal types, disease types and region.
• Market Diversification: Comprehensive information on new products, expanding geographies, current advancements, and investments in the udder health market.
• Competitive Assessment: In-depth analysis of market share, growth strategies, product and service offerings, and capabilities of the main udder health products manufacturers.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 27
1.2.1 INCLUSIONS & EXCLUSIONS 27
1.2.2 MARKET SCOPE 28
1.2.3 YEARS CONSIDERED 29
1.2.4 CURRENCY CONSIDERED 29
1.3 STAKEHOLDERS 30
1.4 RECESSION IMPACT 30
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
2.2 RESEARCH METHODOLOGY DESIGN 32
2.2.1 SECONDARY DATA 32
2.2.1.1 Key data from secondary sources 33
2.2.2 PRIMARY DATA 33
2.2.2.1 Key data from primary sources 34
2.2.2.2 Key industry insights 35
2.3 MARKET SIZE ESTIMATION 37
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 42
2.5 MARKET SHARE ESTIMATION 43
2.6 STUDY ASSUMPTIONS 43
2.7 RESEARCH LIMITATIONS 44
2.7.1 METHODOLOGY-RELATED LIMITATIONS 44
2.7.2 SCOPE-RELATED LIMITATIONS 44
2.8 RISK ASSESSMENT 44
2.9 RECESSION IMPACT ANALYSIS 44
3 EXECUTIVE SUMMARY 45
4 PREMIUM INSIGHTS 50
4.1 UDDER HEALTH MARKET OVERVIEW 50
4.2 ASIA PACIFIC: UDDER HEALTH MARKET, BY PRODUCT AND COUNTRY (2023) 51
4.3 UDDER HEALTH MARKET: REGIONAL MIX 52
4.4 UDDER HEALTH MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 52

5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
5.2.1 DRIVERS 54
5.2.1.1 Increasing demand for milk & dairy products 54
5.2.1.2 Rising incidence of mastitis 55
5.2.1.3 Increasing number of veterinary practitioners in developed markets and subsequent focus on preventive health measures 55
5.2.1.4 Technological advancements in udder health monitoring devices 57
5.2.2 RESTRAINTS 58
5.2.2.1 Limited resources and low awareness among small-scale dairy farmers 58
5.2.3 OPPORTUNITIES 58
5.2.3.1 Gradual transition from manual milking to mechanized milking solutions 58
5.2.3.2 Increasing per capita income of farmers in emerging markets 59
5.2.4 CHALLENGES 60
5.2.4.1 Stringent regulatory guidelines for livestock industry 60
5.3 INDUSTRY TRENDS 60
5.3.1 RISING DEMAND FOR ORGANIC UDDER HEALTH PRODUCTS 60
5.3.2 INCREASING R&D ACTIVITIES FOR INNOVATIVE UDDER HEALTH SOLUTIONS 61
5.3.3 EMPHASIS ON SUSTAINABLE PRACTICES 61
5.4 VALUE CHAIN ANALYSIS 61
5.5 TECHNOLOGY ANALYSIS 62
5.5.1 KEY TECHNOLOGIES 62
5.5.1.1 Telemedicine 62
5.5.1.2 AI integration in udder health 63
5.5.2 COMPLEMENTARY TECHNOLOGIES 63
5.5.2.1 Nutritional supplements 63
5.5.2.2 Integration of barn environmental management system 64
5.5.3 ADJACENT TECHNOLOGIES 64
5.5.3.1 Precision livestock farming 64
5.5.3.2 Integration of cattle & livestock management software 65
5.6 PORTER’S FIVE FORCES ANALYSIS 66
5.6.1 THREAT OF NEW ENTRANTS 67
5.6.2 BARGAINING POWER OF SUPPLIERS 67
5.6.3 BARGAINING POWER OF BUYERS 68
5.6.4 THREAT OF SUBSTITUTES 68
5.6.5 COMPETITIVE RIVALRY 68
5.7 REGULATORY LANDSCAPE 69
5.7.1 REGULATORY ANALYSIS 69
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
5.8 PATENT ANALYSIS 74
5.8.1 PATENT PUBLICATION TRENDS FOR UDDER HEALTH MARKET 74
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 75
5.9 TRADE ANALYSIS 77
5.9.1 TRADE ANALYSIS FOR UDDER HEALTH PRODUCTS 77
5.10 PRICING ANALYSIS 78
5.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE 78
5.10.2 AVERAGE SELLING PRICE TREND OF UDDER HEALTH PRODUCTS, BY REGION 78
5.11 REIMBURSEMENT ANALYSIS 79
5.12 KEY CONFERENCES AND EVENTS (2024−2025) 80
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 80
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 80
5.13.2 BUYING CRITERIA 81
5.14 UNMET NEEDS/END-USER EXPECTATIONS IN UDDER HEALTH MARKET 82
5.15 ECOSYSTEM ANALYSIS 82
5.16 CASE STUDY ANALYSIS 85
5.16.1 EARLY MASTITIS DETECTION WITH SENSOR TECHNOLOGY 85
5.16.2 AUTOMATION OF PRE-TEAT DIPPING FOR HIGH EFFICIENCY 85
5.16.3 UTILIZING HERD MANAGEMENT SOFTWARE FOR DATA-DRIVEN DECISIONS 86
5.17 SUPPLY CHAIN ANALYSIS 86
5.18 ADJACENT MARKETS 88
5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 88
5.20 INVESTMENT & FUNDING SCENARIO 89
6 UDDER HEALTH MARKET, BY PRODUCT 90
6.1 INTRODUCTION 91
6.2 DEVICES 91
6.2.1 MILK QUALITY ANALYZERS 93
6.2.1.1 Ability to ensure quality & safety to drive market 93
6.2.2 MILK SAMPLING EQUIPMENT 94
6.2.2.1 Growing demand for automated sampling systems and manual sampling kits to drive market 94
6.2.3 MILK MANAGEMENT SYSTEMS 96
6.2.3.1 Rising technological advancements to support market growth 96
6.2.4 OTHER UDDER HEALTH DEVICES 97
6.3 PHARMACEUTICALS 99
6.3.1 ANTIBIOTICS 100
6.3.1.1 Advancements in formulations and delivery methods to propel market 100
6.3.2 VACCINES 102
6.3.2.1 Growth in dairy farm sector to boost demand 102

6.3.3 ANTI-INFLAMMATORY DRUGS 103
6.3.3.1 Innovative product launches to support market growth 103
6.3.4 INTRAMAMMARY INFUSIONS 105
6.3.4.1 Ability to provide targeted treatment during dry season to drive market 105
6.3.5 TEAT SEALANTS 106
6.3.5.1 Antimicrobial properties to drive market 106
6.3.6 OTHER UDDER HEALTH PHARMACEUTICALS 108
6.4 SUPPLEMENTS 109
6.4.1 VITAMINS & MINERALS 110
6.4.1.1 Essential requirement for optimal health of dairy cattle to fuel uptake 110
6.4.2 PROBIOTICS & PREBIOTICS 111
6.4.2.1 Growing demand for nutraceuticals to drive market 111
6.4.3 OTHER UDDER HEALTH SUPPLEMENTS 112
7 UDDER HEALTH MARKET, BY VETERINARY CARE SETTING 114
7.1 INTRODUCTION 115
7.2 DAIRY FARMS 115
7.2.1 GROWING DEMAND FOR MILK & DAIRY PRODUCTS TO DRIVE MARKET 115
7.3 VETERINARY HOSPITALS AND CLINICS 116
7.3.1 INCREASING ESTABLISHMENT OF CLINICAL PRACTICES ACROSS EMERGING ECONOMIES TO SUPPORT MARKET GROWTH 116
8 UDDER HEALTH MARKET, BY ANIMAL TYPE 118
8.1 INTRODUCTION 119
8.2 DAIRY CATTLE 120
8.2.1 GROWTH IN CATTLE POPULATION TO DRIVE MARKET 120
8.3 OTHER ANIMAL TYPES 121
9 UDDER HEALTH MARKET, BY DISEASE TYPE 123
9.1 INTRODUCTION 124
9.2 CLINICAL MASTITIS 125
9.2.1 INCREASING PREVALENCE AND HIGH COSTS ASSOCIATED WITH TREATMENT TO PROPEL MARKET 125
9.3 OTHER DISEASE TYPES 126
10 UDDER HEALTH MARKET, BY REGION 129
10.1 INTRODUCTION 130
10.2 NORTH AMERICA 130
10.2.1 NORTH AMERICA: RECESSION IMPACT 131
10.2.2 US 134
10.2.2.1 Increasing number of veterinary practitioners to drive market 134
10.2.3 CANADA 137
10.2.3.1 High R&D investments for udder monitoring products to drive market 137
10.3 EUROPE 140
10.3.1 EUROPE: RECESSION IMPACT 141
10.3.2 GERMANY 145
10.3.2.1 Advanced dairy farming practices to fuel uptake 145
10.3.3 UK 148
10.3.3.1 High adoption of advanced veterinary technologies to propel market 148
10.3.4 FRANCE 151
10.3.4.1 Expanding dairy industry to support market growth 151
10.3.5 ITALY 154
10.3.5.1 Growing investments in udder health solutions to drive market 154
10.3.6 SWITZERLAND 157
10.3.6.1 Growing demand for mastitis detectors to fuel uptake 157
10.3.7 SPAIN 160
10.3.7.1 Increasing establishment of dairy farms to boost demand 160
10.3.8 REST OF EUROPE 163
10.4 ASIA PACIFIC 166
10.4.1 ASIA PACIFIC: RECESSION IMPACT 167
10.4.2 JAPAN 172
10.4.2.1 Growing focus on automated milking systems to boost demand 172
10.4.3 CHINA 175
10.4.3.1 Increase in milk consumption to propel market 175
10.4.4 INDIA 178
10.4.4.1 Growing population of dairy cattle to drive market 178
10.4.5 AUSTRALIA 181
10.4.5.1 Stringent dairy farming regulations to propel market 181
10.4.6 SOUTH KOREA 184
10.4.6.1 Increasing awareness and adoption of preventive healthcare measures among dairy farmers to drive market 184
10.4.7 REST OF ASIA PACIFIC 187
10.5 LATIN AMERICA 190
10.5.1 LATIN AMERICA: RECESSION IMPACT 190
10.5.2 BRAZIL 194
10.5.2.1 Emphasis on improving milk quality to boost demand 194
10.5.3 MEXICO 197
10.5.3.1 Improvements in animal welfare standards to support market growth 197
10.5.4 REST OF LATIN AMERICA 200
10.6 MIDDLE EAST & AFRICA 203
10.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT 203
10.6.2 GCC COUNTRIES 207
10.6.2.1 Improvements in economic stability to support market growth 207
10.6.3 REST OF MIDDLE EAST & AFRICA 209
11 COMPETITIVE LANDSCAPE 213
11.1 OVERVIEW 213
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 213
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN UDDER HEALTH MARKET 214
11.3 REVENUE ANALYSIS 214
11.4 MARKET SHARE ANALYSIS 215
11.4.1 RANKING OF KEY MARKET PLAYERS 217
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 217
11.5.1 STARS 217
11.5.2 EMERGING LEADERS 217
11.5.3 PERVASIVE PLAYERS 218
11.5.4 PARTICIPANTS 218
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 219
11.5.5.1 Company footprint 219
11.5.5.2 Region footprint 220
11.5.5.3 Product footprint 221
11.5.5.4 Veterinary care setting footprint 222
11.5.5.5 Animal type footprint 223
11.5.5.6 Disease type footprint 224
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 225
11.6.1 PROGRESSIVE COMPANIES 225
11.6.2 RESPONSIVE COMPANIES 225
11.6.3 DYNAMIC COMPANIES 225
11.6.4 STARTING BLOCKS 226
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 227
11.7 COMPANY VALUATION AND FINANCIAL METRICS 228
11.7.1 FINANCIAL METRICS 228
11.7.2 COMPANY VALUATION 228
11.8 R&D EXPENDITURE OF KEY PLAYERS 229
11.9 BRAND/PRODUCT COMPARISON 229
11.10 COMPETITIVE SCENARIO 230
11.10.1 PRODUCT LAUNCHES & APPROVALS 230
11.10.2 DEALS 231
11.10.3 EXPANSIONS 231
11.10.4 OTHER DEVELOPMENTS 232
12 COMPANY PROFILES 233
12.1 KEY PLAYERS 233
12.1.1 VETOQUINOL S.A. 233
12.1.1.1 Business overview 233
12.1.1.2 Products offered 234
12.1.1.3 Recent developments 235
12.1.1.3.1 Deals 235
12.1.1.3.2 Other developments 235
12.1.1.4 MnM view 235
12.1.1.4.1 Key strengths 235
12.1.1.4.2 Strategic choices 235
12.1.1.4.3 Weaknesses & competitive threats 236
12.1.2 ZOETIS INC. 237
12.1.2.1 Business overview 237
12.1.2.2 Products offered 238
12.1.2.3 Recent developments 239
12.1.2.3.1 Product launches 239
12.1.2.3.2 Expansions 239
12.1.2.4 MnM view 239
12.1.2.4.1 Key strengths 239
12.1.2.4.2 Strategic choices 239
12.1.2.4.3 Weaknesses & competitive threats 240
12.1.3 MERCK & CO., INC. 241
12.1.3.1 Business overview 241
12.1.3.2 Products offered 242
12.1.3.3 Recent developments 243
12.1.3.3.1 Product launches & approvals 243
12.1.3.4 MnM view 243
12.1.3.4.1 Key strengths 243
12.1.3.4.2 Strategic choices 243
12.1.3.4.3 Weaknesses & competitive threats 243
12.1.4 VIRBAC 244
12.1.4.1 Business overview 244
12.1.4.2 Products offered 245
12.1.4.3 MnM view 246
12.1.4.3.1 Key strengths 246
12.1.4.3.2 Strategic choices 246
12.1.4.3.3 Weaknesses & competitive threats 246
12.1.5 ECOLAB 247
12.1.5.1 Business overview 247
12.1.5.2 Products offered 248
12.1.5.3 Recent developments 249
12.1.5.3.1 Product launches 249
12.1.5.3.2 Deals 249
12.1.6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 250
12.1.6.1 Business overview 250
12.1.6.2 Products offered 251
12.1.6.3 MnM view 252
12.1.6.3.1 Key strengths 252
12.1.6.3.2 Strategic choices 252
12.1.6.3.3 Weaknesses & competitive threats 252
12.1.7 ELANCO ANIMAL HEALTH INCORPORATED 253
12.1.7.1 Business overview 253
12.1.7.2 Products offered 254
12.1.8 DELAVAL 255
12.1.8.1 Business overview 255
12.1.8.2 Products offered 256
12.1.8.3 Recent developments 258
12.1.8.3.1 Product launches 258
12.1.8.3.2 Other developments 258
12.1.9 ORFFA 259
12.1.9.1 Business overview 259
12.1.9.2 Products offered 259
12.1.9.3 Recent developments 259
12.1.9.3.1 Deals 259
12.1.10 AHV INTERNATIONAL B.V. 260
12.1.10.1 Business overview 260
12.1.10.2 Products offered 260
12.1.11 BOUMATIC LLC 261
12.1.11.1 Business overview 261
12.1.11.2 Products offered 261
12.1.12 GEA GROUP AKTIENGESELLSCHAFT 262
12.1.12.1 Business overview 262
12.1.12.2 Products offered 263
12.1.13 G SHEPHERD ANIMAL HEALTH 264
12.1.13.1 Business overview 264
12.1.13.2 Products offered 264
12.1.13.3 Recent developments 265
12.1.13.3.1 Other developments 265
12.1.14 CEVA SANTÉ ANIMALE 266
12.1.14.1 Business overview 266
12.1.14.2 Products offered 266
12.2 OTHER PLAYERS 267
12.2.1 ALBERT KERBL GMBH: COMPANY OVERVIEW 267
12.2.2 AMBIC EQUIPMENT LIMITED: COMPANY OVERVIEW 269
12.2.3 LELY: COMPANY OVERVIEW 271
12.2.4 ZENEX ANIMAL HEALTH INDIA PRIVATE LTD.: COMPANY OVERVIEW 273
12.2.5 DRAMINSKI S. A.: COMPANY OVERVIEW 275
12.2.6 RING BIOTECHNOLOGY CO LTD.: COMPANY OVERVIEW 276
12.2.7 NICOSIA BIOLABS INTERNATIONAL PRIVATE LIMITED: COMPANY OVERVIEW 277
12.2.8 BLACKMANGO HERBS: COMPANY OVERVIEW 278
12.2.9 KORU DIAGNOSTICS LTD.: COMPANY OVERVIEW 278
12.2.10 MASTAPLEX: COMPANY OVERVIEW 279
12.2.11 ARBROWN CO., JP LTD.: COMPANY OVERVIEW 279
13 APPENDIX 280
13.1 DISCUSSION GUIDE 280
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 287
13.3 CUSTOMIZATION OPTIONS 289
13.4 RELATED REPORTS 289
13.5 AUTHOR DETAILS 290